Brief: Lipocine-On Dec 6, 2022 Co Received Notification From Nasdaq Indicating Will Have Additional 180-Day Grace Period,Until June 5,2023,To Regain Compliance
07/12/2022 22:21
Dec 7 (Reuters) - Lipocine Inc LPCN.O :
* LIPOCINE-ON DEC 6, 2022 CO RECEIVED NOTIFICATION FROM
NASDAQ
INDICATING WILL HAVE ADDITIONAL 180-DAY GRACE PERIOD,UNTIL JUNE
5,2023,TO REGAIN COMPLIANCE
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy